Terns Pharmaceuticals Inc (TERN)

05:03 AM

43,857 Shares in Terns Pharmaceuticals, Inc. $TERN Acquired by SG Americas Securities LLC - MarketBeat

05:03 AM

04:51 AM

Capricorn Fund Managers Ltd Takes $6.12 Million Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat

04:51 AM

03:54 AM

Merck nears deal to buy Terns Pharmaceuticals - MSN

03:54 AM

Apr 05, 2026

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - msn.com

Apr 05, 2026

Apr 05, 2026

Aug Mood: Can Terns Pharmaceuticals Inc be the next market leaderGap Up & Real-Time Stock Entry Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Barclays downgrades Terns Pharmaceuticals (TERN) - MSN

Apr 03, 2026

Apr 03, 2026

Terns Pharmaceuticals Grants Inducement Shares to New Employees - National Today

Apr 03, 2026

Apr 02, 2026

Emil Kuriakose Sells 942 Shares of Terns Pharmaceuticals (NASDAQ:TERN) Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Terns Pharmaceuticals (TERN) CMO sells shares to cover RSU taxes - Stock Titan

Apr 02, 2026

Apr 02, 2026

Press Release: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - Moomoo

Apr 02, 2026

Apr 02, 2026

Merck's $6.7 billion Terns Pharmaceuticals acquisition may face rival interest: Analyst - MSN

Apr 02, 2026

Apr 02, 2026

Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com

Apr 02, 2026

Apr 02, 2026

Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView

Apr 02, 2026

Apr 02, 2026

Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Apr 02, 2026

Apr 02, 2026

Three new Terns employees get 23,316 stock units over 4 years - Stock Titan

Apr 02, 2026

Apr 02, 2026

Merck nears $6 billion deal to buy Terns Pharma: Report - MSN

Apr 02, 2026

Apr 02, 2026

Merck Just Made a Big Bet on a New Cancer Growth Engine - Investing.com

Apr 02, 2026

Apr 02, 2026

Assessing Terns Pharmaceuticals (TERN) Valuation After Strong Recent Share Price Momentum - Yahoo Finance

Apr 02, 2026

Apr 02, 2026

Terns Pharmaceuticals, Inc. $TERN Shares Purchased by JPMorgan Chase & Co. - MarketBeat

Apr 02, 2026

Apr 02, 2026

TERN Stock Chart | TERNS PHARMACEUTICALS INC (NASDAQ:TERN) - ChartMill

Apr 02, 2026

Apr 01, 2026

Merck & Co. (MRK) to acquire Terns Pharma for $6.7 billion - msn.com

Apr 01, 2026

Apr 01, 2026

This Terns Pharmaceuticals analyst is no longer bullish; here are top 4 downgrades for Monday - MSN

Apr 01, 2026

Apr 01, 2026

Merck to buy Terns for $6.7 billion to grow in blood cancers - msn.com

Apr 01, 2026

Apr 01, 2026

Truist Securities downgrades Terns Pharmaceuticals (TERN) - msn.com

Apr 01, 2026

Mar 31, 2026

Investors question premium in Merck's $6.7B deal for Terns Pharmaanalyst - msn.com

Mar 31, 2026

Mar 31, 2026

Terns Pharma (TERN) Downgraded by Truist Securities with Lowered Price Target | TERN Stock News - gurufocus.com

Mar 31, 2026

Mar 31, 2026

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Hold" Rating from Truist Financial - MarketBeat

Mar 31, 2026

Mar 31, 2026

Terns Pharmaceuticals (NASDAQ:TERN) Issues Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat

Mar 31, 2026

Mar 31, 2026

Barclays Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Cuts Target Price to $53 - Moomoo

Mar 31, 2026

Mar 31, 2026

Terns Pharmaceuticals | 10-K: Annual report - Moomoo

Mar 31, 2026

Mar 31, 2026

SLS vs. TERN: Which pharma stock has more upside as Merck eyes $6B cancer bet ahead of Keytruda patent cliff - MSN

Mar 31, 2026

Mar 31, 2026

Merck to acquire Terns in $6.7 billion deal – signaling fresh push in competitive cancer drug race - MSN

Mar 31, 2026

Mar 30, 2026

Truist Financial Downgrades Terns Pharmaceuticals(TERN.US) to Hold Rating, Cuts Target Price to $53 - Moomoo

Mar 30, 2026

Mar 30, 2026

Terns Pharmaceuticals 10-K: $0 Revenue, $(1.03) EPS - TradingView

Mar 30, 2026

Mar 30, 2026

Terns Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Merck to buy Terns Pharmaceuticals (NASDAQ: TERN) for $53 per share in cash - Stock Titan

Mar 30, 2026

Mar 30, 2026

Barclays Downgrades Terns Pharma (TERN) Rating and Lowers Price Target | TERN Stock News - GuruFocus

Mar 30, 2026

Mar 30, 2026

Terns Pharmaceuticals (NASDAQ:TERN) Earns "Equal Weight" Rating from Barclays - MarketBeat

Mar 30, 2026

Mar 30, 2026

This Terns Pharmaceuticals Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Monday - Benzinga

Mar 30, 2026

Mar 30, 2026

Terns Pharmaceuticals faces final earnings under acquisition cloud By Investing.com - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Terns Pharmaceuticals faces final earnings under acquisition cloud - investing.com

Mar 30, 2026

Mar 30, 2026

Merck to Buy Terns Pharmaceuticals to Strengthen Drug Pipeline - Chemical Industry Digest

Mar 30, 2026

Mar 30, 2026

Barclays Downgrades Terns Pharmaceuticals to Equalweight From Overweight, Cuts Price Target to $53 From $56 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

Barclays cuts Terns Pharmaceuticals stock rating on Merck deal By Investing.com - Investing.com Canada

Mar 30, 2026